Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA advisory panel to review Paxene for KS

Aug. 6, 1997

Paclitaxel approved by FDA for AIDS-related KS

Aug. 6, 1997

NIH study shows TB prophylaxis unnecessary in HIV-infected patients

Aug. 1, 1997

Caelyx approved in Australia and New Zealand

July 31, 1997

New protease inhibitor from HMR characterized

July 30, 1997

Advantage-24 safe for evaluation in HIV prevention

July 29, 1997

Hybridon suspends development of GEM-91 for AIDS

July 28, 1997

HIV protease inhibitors from Novartis

July 17, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

Roche rights to Viracept expanded

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...